Mitra Keluarga Karyasehat (MIKA.IJ) Resilient Growth at Undemanding Valuation
We lowered our FY26/27F EBITDA est. by 3/5% and TP to Rp3,300, but maintain Buy rating on attractive valuation and resilient growth outlook.
94 Views
Mitra Keluarga Karyasehat (MIKA IJ) Durable Margin Expansion, Overlooked by The Market
9M25 results beat (80%/81% of our/cons. FY25F) was driven by higher private patient mixes and contained salary cost, supporting margin.
321 Views
Mitra Keluarga Karyasehat (MIKA.IJ) - An Overlooked Best-Performing Indonesian Hospital
1H25 earnings reflected MIKA’s resilient cost-control and ability to retain private patients, despite being impacted by subdued volume growth.
501 Views
Healthcare: 3Q25 Preview: Hospitals Soft Vs. Consensus, Pharma Stable
Hospitals: 3Q25 patient vol. improved yoy from a low 3Q24 base; 9M25 in line with our (77%) but may miss cons (68%), HEAL & SILO drags.
184 Views
Equity Strategy: Oct25 Picks: Sticking with Banks, Commodities, Telco
We maintain our positive stance on Banks as we expect better liquidity condition to be reflected in Sep25 CoF, combined with attractive yield.
460 Views